» Authors » Lane Bushman

Lane Bushman

Explore the profile of Lane Bushman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 1075
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mainella V, Branchford B, Nemkov T, Hosford S, Coyle R, Johnson B, et al.
J Antimicrob Chemother . 2025 Mar; PMID: 40037647
Background: Previous studies have primarily focused on nucleos(t)ide reverse transcriptase inhibitor pharmacology in peripheral blood mononuclear cells (PBMCs) and erythrocytes via dried blood spots (DBS), but not other major blood...
2.
Zhang H, Mock M, Bushman L, Anderson P, Kiser J, Naggie S
Clin Infect Dis . 2024 May; 79(3):705-708. PMID: 38703389
This case-control study explored cumulative tenofovir exposure among patients with human immunodeficiency virus/hepatis B virus (HIV/HBV) coinfection with HIV viral suppression. Among patients taking tenofovir disoproxil fumarate, median TFV-DP levels...
3.
Mainella V, Morrow M, Brooks K, Bushman L, Abdelmawla F, Nerguizian D, et al.
AIDS Res Hum Retroviruses . 2023 Jun; 40(5):227-230. PMID: 37382422
The purpose of this study was to evaluate the relationship between intracellular islatravir-triphosphate (ISL-TP) in paired peripheral blood mononuclear cells (PBMCs) and dried blood spots (DBS). Three pig-tailed macaques (PMs)...
4.
Cattani V, Moreira Jalil E, Eksterman L, Torres T, Cardoso S, Castro C, et al.
Clin Pharmacokinet . 2023 Jun; 62(7):1031-1041. PMID: 37261664
Background And Objective: An important barrier to HIV prevention among transgender women (TGW) is the concern that oral pre-exposure prophylaxis (PrEP) negatively affects the efficacy of feminizing hormone therapy (FHT)....
5.
Cattani V, Moreira Jalil E, Eksterman L, Torres T, Cardoso S, Castro C, et al.
J Antimicrob Chemother . 2022 Jul; 77(10):2729-2736. PMID: 35815666
Objectives: Potential interactions between feminizing hormone therapy (FHT) and pre-exposure prophylaxis (PrEP) may be a barrier to PrEP use among transgender women (TGW). We aimed to assess the impact of...
6.
Yager J, Brooks K, Castillo-Mancilla J, Nemkov C, Morrow M, Peterson S, et al.
AIDS . 2021 Sep; 35(15):2481-2487. PMID: 34482350
Objective: Tenofovir alafenamide (TAF) preferentially loads peripheral blood mononuclear cells (PBMCs), resulting in higher PBMC tenofovir-diphosphate (TFV-DP) vs. tenofovir disoproxil fumarate (TDF). No studies have yet compared TFV-DP in PBMC...
7.
Morin L, Behanzin L, Guedou F, Keke R, Bushman L, Anderson P, et al.
Sex Transm Dis . 2021 Feb; 48(9):654-662. PMID: 33633072
Background: Benin has a long-standing history of HIV prevention programs aimed at female sex workers (FSWs). We used data from a national survey among FSWs (2017) to assess the prevention...
8.
Ellsworth G, Burke L, Wells M, Mishra S, Caffrey M, Liddle D, et al.
J Acquir Immune Defic Syndr . 2020 Dec; 86(1):73-80. PMID: 33306564
Background: Adherence is critical to achieve the benefits of antiretroviral therapy. A smart-pill bottle service that transmits real-time adherence data via cellular networks to a central service and prompts nonadherent...
9.
Ibrahim M, Castillo-Mancilla J, Yager J, Brooks K, Bushman L, Saba L, et al.
AIDS Res Hum Retroviruses . 2020 Nov; 37(6):421-428. PMID: 33191774
Tenofovir diphosphate (TFV-DP) concentrations measured with dried blood spots (DBS) can be used to classify adherence to emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP). A TFV-DP of 700...
10.
Vernon F, Morrow M, MaWhinney S, Coyle R, Coleman S, Ellison L, et al.
Open Forum Infect Dis . 2020 Oct; 7(10):ofaa391. PMID: 33072812
Background: The adherence biomarker tenofovir diphosphate (TFV-DP) in dried blood spots (DBS) is associated with viral suppression and predicts future viremia. However, its association with social determinants of health (SDoH)...